Application of recombinant protein technologies in the development of innovative medical devices for BV treatment (Q3798321): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
(‎Changed label, description and/or aliases in fr: translated_label)
label / frlabel / fr
 
Application des technologies des protéines recombinantes dans le développement de dispositifs médicaux innovants pour le traitement de la VB

Revision as of 10:33, 28 November 2021

Project Q3798321 in Lithuania
Language Label Description Also known as
English
Application of recombinant protein technologies in the development of innovative medical devices for BV treatment
Project Q3798321 in Lithuania

    Statements

    0 references
    1,110,770.11 Euro
    0 references
    Uždaroji akcinė bendrovė "Profarma"
    0 references
    0 references

    Identifiers

    J05-LVPA-K-04-0085
    0 references